The FTSE 100 group will plough £450m into researching, developing and manufacturing new vaccines at its plant in Speke, Liverpool.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.